STANBROOK STEVEN P

Director Stanbrook bought 54,540 shares of PRMB at $16.43; stock down 53.9% from 52-week high; cluster pattern with 3 other insiders.

STANBROOK STEVEN P (Director) purchased 54,540 shares at $16.43 on 2025-11-13, increasing his holdings by 42.9% to 181,601 shares. This buy occurs while PRMB trades at $16.42, down 26.8% over 30 days and 33.1% over 90 days from levels 53.9% below the 52-week high of $35.63. Importantly, this filing is part of a cluster pattern with 3 other insiders also buying within the past 14 days, suggesting coordinated confidence among the leadership group. However, Stanbrook's cross-ticker track record shows 0 wins at the 90-day horizon with an average 90d return of -35.3%, and his only prior PRMB buy (2025-08-12) also underperformed at 90 days, raising questions about the timing or foresight of insider purchases in this account's pattern. The company's fundamentals show revenue of $1,766,100,000.00 and net income of $16,800,000.00 for the latest quarter, though it was unprofitable over its most recent full fiscal year.

Director Stanbrook buys 12,400 shares of PRMB at $24.04; third insider buy in 14 days amid -31.0% from high

STANBROOK STEVEN P, a director, purchased 12,400 shares at $24.04 on 2025-08-12, raising his holdings from 112,625 to 125,025 shares. This transaction is part of a cluster pattern: 2 other insiders also bought within the past 14 days. The purchase occurs while the stock is -31.0% from its 52-week high of $35.63 and -24.0% over the past 90 days, suggesting a valuation window for insider acquisition. However, the company was unprofitable over its most recent full fiscal year despite recent quarterly revenue of $1.7B and annual revenue growth of +9.7%, creating a mixed financial backdrop. Multiple insider purchases within a short timeframe merit monitoring, though the lack of profitability leaves the signal ambiguous.